June 10, 2004
Cannabis-based medicine may help arthritis patients : News
(Source:'GW cannabis drug hope for arthritis' : Financial Times, p. 25, 10 Jun 2004)
The makers of the cannabis-based medicine, Sativex, claim that the product has shown positive results in a phase II clinical trial involving 58 rheumatoid arthritis sufferers. GW Pharmaceuticals is already seeking regulatory approval for Sativex as a prescription treatment for multiple sclerosis and neuropathic pain. The company will now move into late-stage trials of the drug – administered in an oral spray – for arthritis treatment.
« Seat on LA Neighborhood Council for 'skid row' resident |
| Drugnet Europe 46 »